AirSculpt Technologies, Inc. filings document the regulatory record of a public medical aesthetics company that provides premium body contouring procedures. Its 8-K reports cover operating and financial results, preliminary updates, non-GAAP financial measures, reconciliations, debt and capital-structure disclosures, material agreements, and governance events.
Proxy materials describe annual meeting matters, director elections, shareholder voting items, board structure, and related governance disclosures. Other filings include late-filing notices tied to annual report timing, amendments correcting non-GAAP presentation, and emerging growth company status under SEC reporting rules.
Airsculpt Technologies, Inc. major holder Jorey Chernett bought additional shares of the company. On this Form 4, Chernett reported an open-market purchase of 45,600 shares of common stock at a weighted average price of about $2.00 per share, increasing his direct holdings to 6,398,211 shares.
Airsculpt Technologies, Inc. Schedule 13G/A shows that Jorey Chernett beneficially owned 6,781,811 shares of Common Stock as of the close of business on March 4, 2026, representing 10.79% of the class. The percentage is calculated using 62,436,670 Shares outstanding as of November 6, 2025, as disclosed in the issuer's Form 10-Q.
The filing states voting and dispositive power are held solely by the Reporting Person for the listed shares and that some of the shares are underlying currently exercisable call options.
Airsculpt Technologies, Inc. disclosed that 10% owner Jorey Chernett bought a total of 110,000 shares of common stock in open-market purchases. He acquired 80,000 shares at a weighted-average price of $1.71 on March 3 and 30,000 shares at $1.87 on March 4. According to the filing, these were executed in multiple trades at prices ranging from $1.67 to $1.77 and from $1.86 to $1.88. Following these purchases, Chernett directly owns 6,352,611 Airsculpt shares.
Airsculpt Technologies, Inc. major shareholder Jorey Chernett filed an initial Form 3 showing existing holdings in the company. The filing lists direct ownership of call options covering 429,200 shares and 6,242,611 shares of common stock, both as of the reported date, reflecting more than 10% beneficial ownership.
Parian Ultreia reports a significant passive stake in Airsculpt Technologies, Inc. The firm reports beneficial ownership of 3,180,000 shares of AirSculpt Technologies, representing 5.09% of the class, with sole voting and dispositive power over all reported shares as of the event date.
The filer certifies the shares were not acquired and are not held to change or influence control of Airsculpt Technologies, but instead as a passive investment. No other persons or subsidiaries are reported as having beneficial ownership or group status in connection with this holding.
Airsculpt Technologies, Inc. (AIRS) received an amended beneficial ownership report from SW Investment Management LLC and Partners LP. The filing states that, as of the event date, each reporting person beneficially owns 0 shares of Airsculpt common stock, representing 0.0% of the class, based on 62,440,000 shares outstanding.
SW Investment Management LLC is described as the investment manager and general partner of Partners LP, but both entities report no sole or shared voting or dispositive power over any Airsculpt shares. The signatory certifies that any securities referenced were acquired and held in the ordinary course of business and not for the purpose of changing or influencing control of the company.
AirSculpt Technologies, Inc. CEO Yogesh Jashnani reported a tax-related share withholding tied to restricted stock vesting. On February 3, 2026, 55,098 shares of common stock vested from restricted stock units. The company withheld 24,217 shares, valued at $2.58 per share, to cover $62,484.48 of withholding taxes. After this transaction, Jashnani directly beneficially owned 496,759 shares of AirSculpt Technologies common stock.
Airsculpt Technologies, Inc. received an updated ownership report showing that individual investor Jorey Chernett beneficially owns 6,156,061 shares of its common stock, representing 9.86% of the outstanding class.
Chernett reports sole voting and dispositive power over all these shares and certifies they were not acquired to change or influence control of Airsculpt. The ownership level triggered this amended Schedule 13G filing based on an event dated January 30, 2026.
AirSculpt Technologies' Chief Financial Officer received new equity awards tied to service and performance. On January 24, 2026, the CFO was granted 147,059 restricted stock units (RSUs) and 147,059 performance stock units (PSUs) at a price of $0 per unit.
The RSUs vest in three equal annual installments starting January 24, 2027, contingent on continued employment. Each PSU represents a right to one share of common stock and will vest based on relative total shareholder return over a three-year period compared with the S&P Health Care Select Industry Index, with outcomes ranging from 0% to 200% of the target award.
Jorey Chernett has filed a Schedule 13G reporting a significant passive stake in Airsculpt Technologies, Inc. He reports beneficial ownership of 3,188,767 shares of Airsculpt common stock, representing 5.11% of the outstanding class as of the filing date. Chernett has sole power to vote and to dispose of all 3,188,767 shares, with no shared voting or dispositive power disclosed.
He certifies that the shares were not acquired and are not held for the purpose of changing or influencing control of Airsculpt, but instead are held on a passive basis consistent with Schedule 13G requirements.